H3B-6545 [2052130-80-8]

MedChem Express

H3B-6545 [2052130-80-8]

10

2052130-80-8

Research Use Only

99.44

C30H29F4N5O2

567.58

H3B-6545 is an oral, selective estrogen receptor covalent antagonist (SERCA) for the research of metastatic ER-positive, HER2-negative breast cancer[1][2].

O=C(N(C)C)/C=C/CNCCOC1=NC=C(/C(C2=CC3=C(NN=C3F)C=C2)=C(C4=CC=CC=C4)/CC(F)(F)F)C=C1

-20°C

12352200